A phase Ib study of preoperative lapatinib, paclitaxel, and gemcitabine combination therapy in women with HER2-positive early breast cancer.
Year: 2011
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: I. H. Park, K. S. Lee, H. S. Kang, Y. Kwon, S. W. Kim, S. Lee, S. Y. Jung, K. H. Shin, K. Ko, B. Nam, J. Ro
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2589849042